Thursday, July 19, 2012

American Council on Science and Health Today

______

More Nonsense from Nature Nuts - Dr. Bloom takes on “The People’s Chemist” (Medical Progress Today)
Dr. Bloom takes on the inaccurate claims of "The People's Chemist," Shane Ellison.

"Mr. Gorbachev — Tear Down This Lab!" (Medical Progress Today)
Dr. Bloom's take on the latest dismal round of lay-offs in the pharmaceutical industry.

Binge drinking decreases memory and cognitive function in seniors
As the Alzheimer’s Association International Conference 2012 in Vancouver, Canada wraps up today, we find ourselves inundated with new findings related to the disease. Among these were two studies revealing that binge drinking among older people increases the risk of cognitive decline and memory loss.

When it comes to infections, don’t judge a hospital by its art collection
We’d like to applaud former ACSH trustee Dr. Betsy McCaughey, whose recent op-ed in the Daily News discusses the current state of hospital hygiene — or lack thereof.

Watchful waiting, not surgery, seems best for early prostate cancer
Results from a study out of the University of Minnesota have added to the ongoing debate over the most effective approach towards the diagnosis and treatment of early-stage prostate cancer. The study, reported in the New England Journal of Medicine, compared men with early-stage cancer who underwent radical prostatectomy with a group that was followed non-invasively, using “active surveillance.” The findings? Neither overall mortality nor cancer-specific mortality significantly differed.

FDA approves second weight loss drug, Qysmia
Last month, the FDA approved Arena Pharmaceuticals’ Belviq (lorcaserin) — the first weight-loss drug to hit the market in over a decade. Now the agency is making headway in the fight to treat obesity as it approves Qsymia (formerly Qnexa), another weight loss drug.

###

No comments: